Sobre 7 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Explore the full record of transactions filed by Rozov Yadin, Consejero. Director active across 4 companies, notably Oramed Pharmaceuticals INC.. Aggregated, 27 filings have been published. Split: 5 buys · 4 sells. Total volume traded: €4.5m. History available since 14 June 2022. The latest transaction was disclosed on 5 June 2026 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Rozov Yadin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Rozov Yadin is a Board Member at Oramed Pharmaceuticals Inc. and Midwest Holding Inc. He brings his expertise to the board, participating in strategy development and oversight of the company's performance.